Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-up.

Samimi M, Sajedi A, Paybast S, Nabavi NS, Karimi S, Yazdanbakhsh S, Gaffari M, Najafian A, Faghani L, Zolfaghari Z, Vosough M, Nabavi SM.

Open source

DOI: 10.1177/20552173251369990
Published: 2025-07-01
Container: Mult Scler J Exp Transl Clin
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20552173251369990,
  title = {Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-up.},
  author = {Samimi M and  Sajedi A and  Paybast S and  Nabavi NS and  Karimi S and  Yazdanbakhsh S and  Gaffari M and  Najafian A and  Faghani L and  Zolfaghari Z and  Vosough M and  Nabavi SM.},
  year = {2025},
  journal = {Mult Scler J Exp Transl Clin},
  doi = {10.1177/20552173251369990},
  url = {https://doi.org/10.1177/20552173251369990}
}

RIS

TY  - JOUR
TI  - Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-up.
AU  - Samimi M
AU  -  Sajedi A
AU  -  Paybast S
AU  -  Nabavi NS
AU  -  Karimi S
AU  -  Yazdanbakhsh S
AU  -  Gaffari M
AU  -  Najafian A
AU  -  Faghani L
AU  -  Zolfaghari Z
AU  -  Vosough M
AU  -  Nabavi SM.
PY  - 2025
JO  - Mult Scler J Exp Transl Clin
DO  - 10.1177/20552173251369990
UR  - https://doi.org/10.1177/20552173251369990
ER  -

APA

M, S., A, S., S, P., NS, N., S, K., S, Y., M, G., A, N., L, F., Z, Z., M, V., & SM., N. (2025). Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-up.. Mult Scler J Exp Transl Clin. https://doi.org/10.1177/20552173251369990

Source records

europe-pmc · retrieved 2026-09-26T12:24:39.293Z